MS
65
3
GM
40
2
UNM
61
2
VRSK
63
-5
SJM
21
2
VLO
40
4
CAT
42
5
DIS
58
-8
ABBV
44
2
AMT
46
-8
URBN
58
2
ORCL
49
3
EA
46
-4
HAS
51
11
MKC
62
3
EXPE
72
5
BAX
47
6
HSIC
54
3
ACN
25
3
FFIV
67
7
MS
65
3
GM
40
2
UNM
61
2
VRSK
63
-5
SJM
21
2
VLO
40
4
CAT
42
5
DIS
58
-8
ABBV
44
2
AMT
46
-8
URBN
58
2
ORCL
49
3
EA
46
-4
HAS
51
11
MKC
62
3
EXPE
72
5
BAX
47
6
HSIC
54
3
ACN
25
3
FFIV
67
7
Financhill
Back

Innovent Biologics 10K Form

Buy
75

IVBXF
Innovent Biologics

Last Price:
$5.98
Seasonality Move:
18.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IVBXF News And Ratings

See the #1 stock for the next 7 days that we like better than IVBXF

IVBXF Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.10
Price / Book: 5.41

Profitability

EPS (TTM): -0.00840
Net Income (TTM): $-13.2M
Gross Margin: $1.1B
Return on Equity: -0.75%
Return on Assets: -0.46%

Innovent Biologics Earnings Forecast

Key Innovent Biologics Financial Ratios

  • The Gross Profit Margin over the past 7 years for IVBXF is 83.97%.
  • The Selling, General & Administrative Expenses for IVBXF have been equal to 53.97% of Gross Profit Margin.
  • The Research & Development expenses have been 28.46% of Revenue.
  • The Net Earning history of IVBXF is -1.00% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Innovent Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: IVBXF
Website: innoventbio.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 2.35
Quick Ratio: 2.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IVBXF Technical Analysis vs Fundamental Analysis

Buy
75
Innovent Biologics (IVBXF) is a Buy

Is Innovent Biologics a Buy or a Sell?